559 related articles for article (PubMed ID: 12747249)
1. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
2. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
3. [Criteria for diagnosing DIC].
Wada H; Abe Y; Nishioka J; Tomatsu H; Nobori T
Rinsho Byori; 2002 Mar; 50(3):273-6. PubMed ID: 11985055
[TBL] [Abstract][Full Text] [Related]
4. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC.
Wada H; Gabazza EC; Asakura H; Koike K; Okamoto K; Maruyama I; Shiku H; Nobori T
Am J Hematol; 2003 Sep; 74(1):17-22. PubMed ID: 12949885
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of DIC based on evidence].
Wada H; Nishioka J; Nobori T; Sakaguchi A; Abe Y
Rinsho Byori; 2006 Nov; 54(11):1172-7. PubMed ID: 17240840
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation.
Takemitsu T; Wada H; Hatada T; Ohmori Y; Ishikura K; Takeda T; Sugiyama T; Yamada N; Maruyama K; Katayama N; Isaji S; Shimpo H; Kusunoki M; Nobori T
Thromb Haemost; 2011 Jan; 105(1):40-4. PubMed ID: 20941463
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
Gupta PK; Gupta M; Chatterjee T; Saxena R
Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
[TBL] [Abstract][Full Text] [Related]
9. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
Sigal SH; Cembrowski GS; Shattil SJ; Brown NM; Schifreen RS; Schwartz MW
Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
[TBL] [Abstract][Full Text] [Related]
10. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
11. [A proposed method for the laboratory diagnosis of disseminated intravascular coagulation in liver cirrhosis].
Cristani A; Cioni G; Mussini C; Pentore R; Zagni G; Ventura E
Recenti Prog Med; 1990 May; 81(5):322-4. PubMed ID: 2377810
[TBL] [Abstract][Full Text] [Related]
12. Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentation.
Yanada M; Matsushita T; Suzuki M; Kiyoi H; Yamamoto K; Kinoshita T; Kojima T; Saito H; Naoe T
Eur J Haematol; 2006 Oct; 77(4):282-7. PubMed ID: 16856920
[TBL] [Abstract][Full Text] [Related]
13. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
14. [Clinical application of laboratory diagnosis: leukemia and DIC].
Deguchi K; Zhao LJ; Shirakawa S
Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
[TBL] [Abstract][Full Text] [Related]
15. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
Egi M; Morimatsu H; Wiedermann CJ; Tani M; Kanazawa T; Suzuki S; Matsusaki T; Shimizu K; Toda Y; Iwasaki T; Morita K
Thromb Haemost; 2009 Apr; 101(4):696-705. PubMed ID: 19350114
[TBL] [Abstract][Full Text] [Related]
16. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of FDP-D-dimer in DIC and pre-DIC].
Takagi M; Wada H; Tanigawa M; Iwasaki E; Deguchi A; Mori Y; Suzuki H; Ohkubo I; Endou T; Deguchi K
Rinsho Byori; 1990 Jul; 38(7):806-12. PubMed ID: 2205744
[TBL] [Abstract][Full Text] [Related]
18. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
19. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
Raschka C; RĂ³ka L
Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic.
Stokol T; Erb HN; De Wilde L; Tornquist SJ; Brooks M
Vet Clin Pathol; 2005 Dec; 34(4):375-82. PubMed ID: 16270263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]